Konofal Eric, Arnulf Isabelle, Lecendreux Michel, Mouren Marie-Christine
Service de Psychopathologie de l'Enfant et de l'Adolescent, Hôpital Robert Debré, Paris, France.
Pediatr Neurol. 2005 May;32(5):350-1. doi: 10.1016/j.pediatrneurol.2004.11.007.
A 6-year-old male being treated with limited efficacy by methylphenidate immediate release for attention-deficit hyperactivity disorder also presented with sleep disruption due to potential restless legs/periodic limb movement syndrome. Treatment with the dopamine agonist ropinirole resulted in a significant improvement in both his attention-deficit hyperactivity disorder symptoms and sleep problems.
一名6岁男性因注意力缺陷多动障碍接受速释型哌甲酯治疗,疗效有限,同时还因潜在的不宁腿/周期性肢体运动综合征出现睡眠障碍。使用多巴胺激动剂罗匹尼罗治疗后,他的注意力缺陷多动障碍症状和睡眠问题均有显著改善。